Press release
Non-Alcoholic Steatohepatitis Drugs Market Segments by Size, Share and Region - Global Forecast to 2026
Non-alcoholic steatohepatitis or NASH is a form of liver disease that causes inflammation and accumulation of fat tissues in the liver. It resembles alcoholic liver disease but occurs to those who drink too little or no alcohol. NASH shows no symptoms and is also known as a “Silent” liver disease. NASH can lead to cirrhosis, in which liver is permanently damaged and scarred and after a certain point, no treatment can cure it and thus lead to death.
There are two types of fatty liver disease: alcoholic fatty liver disease and non-alcoholic fatty liver disease (NAFLD). When inflammation is present with accumulation of fat in the liver then it is referred as NASH. Obesity and diabetes are most common cause of NASH disease. It is a challenge for the patient to recognize the accumulation of fat in the liver as patient experience no such symptoms until reach the advanced stage of the disease. The diagnosis of NASH includes blood tests, MRI, X-rays and liver biopsy.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1351219
Treatment of NASH includes managing and improving the condition of NASH from being worse and is recommended to bring changes in lifestyle and also use of off label drugs to control and manage indications related to NASH. Currently there is no approved drug in the market but is expected to enter the market in 2020. Currently, there are five potential Phase III drugs in the market including Elafibranor, Ocaliva (OCA), Cenicriviroc (CVC), Selonsertib and Aramchol.
The global NASH market is expected to show significant growth after the introduction of therapeutics drugs in 2020. Growth of market will mainly be driven by increasing patient base, rise in obese population, increasing type-2 diabetic population and increasing health expenditure. However, growth of market will also be hindered by absence of effective diagnostics, costly drugs, regulatory challenges and undefined pathogenesis.
The report “Global NASH Drugs Market: Industry Analysis & Outlook (2017-2026)” analyzes the development of this market, with focus on the US and Europe region. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Genfit SA, Intercept Pharmaceuticals, Inc., Allergan Plc. (Tobira) and Gilead Sciences are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global NASH market along with the study of the regional markets.
Browse Complete Report with TOC @ https://www.marketresearchreports.biz/reports/1351219/global-non-alcoholic-steatohepatitis-nash-drugs-market-research-reports/toc
Table of Content
1. Market Overview
1.1 Nonalcoholic Steatohepatitis (NASH)
1.2 Causes & Symptoms
1.3 Diagnosis
1.4 Treatment
2. Global NASH Market
2.1 Global NASH Drugs Market Forecast by Value
2.2 Global NASH Drugs Market Forecast by Drug Class
2.3 Global NASH Off Label Drugs Market Forecast by Value
3. Global NASH Therapeutics Market
3.1 Global NASH Therapeutics Market Forecast by Value
3.2 Global NASH Therapeutics Market Forecast by Drug Type
3.3 Global NASH Therapeutics Market Forecast by Region
3.4 Global NASH Therapeutics Market by Type
3.4.1 Global Elafibranor Revenue Forecast by Value
3.4.2 Global Obeticholic Acid (OCA) Revenue Forecast by Value
3.4.3 Global Obeticholic Acid (OCA) Revenue Forecast by Region
3.4.4 Global Cenicriviroc (CVC) Revenue Forecast by Value
3.4.5 Global Cenicriviroc (CVC) Revenue Forecast by Region
3.4.6 Global Aramchol Revenue Forecast by Value
View Sample PDF @ https://www.marketresearchreports.biz/reports/1351219/global-non-alcoholic-steatohepatitis-nash-drugs-market-research-reports.pdf
4. Regional NASH Market
4.1 The US
4.1.1 The US NASH Therapeutics Market Forecast by Value
4.2 The Europe
4.2.1 Europe NASH Therapeutics Market Forecast by Value
4.3 ROW
4.3.1 ROW NASH Therapeutics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Patient Base
5.1.2 Increasing Population with Type-2 Diabetes
5.1.3 Escalating Obese Population
5.1.4 Rising Healthcare Expenditure
5.1.5 Increasing GDP Per Capita
5.1.6 Vast Unmet Medical Need
5.2 Key Trends & Development
5.2.1 Strong Research & Development Efforts by Companies
5.2.2 Development of NASH Diagnosis Methods and Biomarkers
5.3 Challenges
5.3.1 Absence of Low-Priced and Effective Diagnostics
5.3.2 Regulatory Challenges and Undefined Pathogenesis
5.3.3 Costly NASH Therapeutics
6. Competitive Landscape
6.1 Revenue and Market Cap Comparison
6.2 Major Pipeline Products
7. Company Profiles
7.1 Genfit SA
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Intercept Pharmaceuticals
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Allergan (Tobira)
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Gilead Sciences
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1351219&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis Drugs Market Segments by Size, Share and Region - Global Forecast to 2026 here
News-ID: 890888 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for NASH
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non-Alcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
